From Dual Binding Site Acetylcholinesterase Inhibitors to Multi-Target-Directed Ligands (MTDLs): A Step Forward in the Treatment of Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|8|10|960-967

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.8, Iss.10, 2008-09, pp. : 960-967

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multi-Target-Directed Ligands in Alzheimer's Disease Treatment

By  

Current Medicinal Chemistry, Vol. 18, Iss. 32, 2011-11 ,pp. : 4949-4975

Bentham Science Publishers

Access to resources Recommend Favorite

Peripheral and Dual Binding Site Acetylcholinesterase Inhibitors: Implications in treatment of Alzheimer's Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 3, 2001-09 ,pp. : 267-272

Bentham Science Publishers

Access to resources Recommend Favorite

Peripheral and dual binding site inhibitors of acetylcholinesterase as neurodegenerative disease modifying agents

By Dorronsoro Isabel   Castro Ana   Martinez Ana  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 11, 2003-11 ,pp. : 1725-1732

Informa Healthcare

Access to resources Recommend Favorite

Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 31, 2018-02 ,pp. : 3328-3335

Bentham Science Publishers

Access to resources Recommend Favorite

Structural Determinants of the Multifunctional Profile of Dual Binding Site Acetylcholinesterase Inhibitors as Anti-Alzheimer Agents

By  

Current Pharmaceutical Design, Vol. 16, Iss. 25, 2010-08 ,pp. : 2818-2836

Bentham Science Publishers

Access to resources Recommend Favorite